Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antiangiogenic therapy in leukemia.

D A Thomas1, F J Giles, J Cortes

  • 1Department of Leukemia, M.D. Anderson Cancer Center, Houston, Tex 77030, USA. debthomas@mdanderson.org

Acta Haematologica
|January 30, 2002
PubMed
Summary

Angiogenesis, the process of new blood vessel formation, is crucial in cancer. Targeting this process with antiangiogenic agents offers a promising therapeutic strategy for hematological malignancies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phase II study of elraglusib (9-ING-41), a GSK-3β inhibitor, in combination with gemcitabine plus nab-paclitaxel in previously untreated metastatic pancreatic cancer.

ESMO open·2025
Same author

Acquired Resistance to Poly (ADP-ribose) Polymerase Inhibitor Olaparib in <i>BRCA2</i>-Associated Prostate Cancer Resulting From Biallelic <i>BRCA2</i> Reversion Mutations Restores Both Germline and Somatic Loss-of-Function Mutations.

JCO precision oncology·2019
Same author

Malignancies and ustekinumab: an analysis of the U.S. Food and Drug Administration Adverse Event Reporting System and the European Union Drug Regulating Authorities Pharmacovigilance database.

The British journal of dermatology·2017
Same author

Ecophysiologic investigations in the family of the Mesembryanthemaceae : Occurrence of a CAM and Ion Content.

Oecologia·2017
Same author

Leaf temperatures and energy balance ofWelwitschia mirabilis in its natural habitat.

Oecologia·2017
Same author

Systematic analysis of early phase clinical studies for patients with breast cancer: Inclusion of patients with brain metastasis.

Cancer treatment reviews·2017

Area of Science:

  • Oncology
  • Vascular Biology

Background:

  • Angiogenesis is essential for normal development and healing.
  • Dysregulated angiogenesis supports tumor growth and proliferation in malignant transformation.
  • Cytokines and growth factors driving endothelial cell activity are often altered in hematological malignancies.

Purpose of the Study:

  • To discuss the role of angiogenesis in hematological malignancies.
  • To explore the rationale for using antiangiogenic therapy in these cancers.
  • To review the clinical trial status of novel antiangiogenic agents.

Main Methods:

  • Literature review of angiogenesis in hematological malignancies.
  • Analysis of the rationale for antiangiogenic therapy.
  • Summary of current clinical trials for antiangiogenic agents.

Related Experiment Videos

Main Results:

  • Angiogenesis plays a significant role in the progression of hematological malignancies.
  • Targeting neovascularization is a viable therapeutic strategy.
  • Several antiangiogenic agents are under investigation in clinical trials.

Conclusions:

  • Modulating the angiogenic cascade is a key consideration for eradicating malignant clones.
  • Antiangiogenic therapies show potential for treating hematological malignancies.
  • Further research and clinical trials are needed to establish the efficacy of these agents.